Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Cancers (Basel) ; 15(19)2023 Oct 04.
Article in English | MEDLINE | ID: mdl-37835547

ABSTRACT

BACKGROUND: The interruption of the activity of population-based organized colorectal cancer (CRC) screening programs due to the COVID pandemic may have affected their results in terms of the detection of preneoplastic lesions and CRC. We evaluated the impact of the COVID pandemic on the delays, participation, adherence to colonoscopies, lesions detected, and CRC stage at diagnosis in a CRC screening program. METHODS: We analyzed all the invitations between 1 January 2019 and 31 December 2021. We defined the pandemic period as the period after 12 March 2020. We calculated the delay intervals (successive and all rounds), the rates of participation, adherence to colonoscopy after a positive fecal immunochemical test (FIT), and the diagnostic yield of colonoscopy, specifically of CRC and colorectal neoplasia (CRC and/or adenoma), as well as the CRC stage at diagnosis. RESULTS: In the period analyzed, 976,187 invitations were sent (61.0% in the pandemic period), 439,687 FIT were returned (62.4% in the pandemic period) and 23,092 colonoscopies were performed (59.1% in the pandemic period). The colonoscopies were normal in 7378 subjects (32.4%) and CRC was detected in 916 subjects (4.0%). In successive rounds, the delay increased significantly by seven months during the pandemic period (p < 0.001). In all the invitations, the delay from the invitation to the colonoscopy increased significantly by 8 days (p < 0.001). Once adjusted for the confounding variables, the participation in the screening program increased significantly (OR = 1.1; 95% CI = 1.09-1.11), with no changes in the adherence to colonoscopy (OR = 0.9; 95% CI = 0.8-1.0). We found no differences in the diagnostic yield of colonoscopy in terms of CRC (OR = 0.90; 95% CI = 0.78-1.02) or colorectal neoplasia (OR = 0.98; 95% CI = 0.92-1.03) detection. Finally, we found no differences in the CRC stage at diagnosis (p = 0.2). CONCLUSIONS: Although the interruption of the CRC screening program due to the COVID pandemic increased the delays, it did not reduce participation, adherence to colonoscopy, or the diagnostic yield of colonoscopy.

2.
Diagnostics (Basel) ; 11(9)2021 Aug 24.
Article in English | MEDLINE | ID: mdl-34573862

ABSTRACT

Colorectal cancer (CRC) screening programs have been implemented to reduce the burden of the disease. When an advanced colonic lesion is detected, clinical practice guidelines recommend endoscopic surveillance with different intervals between explorations. Endoscopic surveillance is producing a considerable increase in the number of colonoscopies, with a limited effect on the CRC incidence. Instead, participation in CRC screening programs based on the fecal immunochemical test (FIT) could be a non-inferior alternative to endoscopic surveillance to reduce 10-year CRC incidence. Based on this hypothesis, we have designed a multicenter and randomized clinical trial within the Spanish population CRC screening programs to compare FIT surveillance with endoscopic surveillance. We will include individuals aged from 50 to 65 years with complete colonoscopy and advanced lesions resected within the CRC screening programs. Patients will be randomly allocated to perform an annual FIT and colonoscopy if fecal hemoglobin concentration is ≥10 µg/g, or to perform endoscopic surveillance. On the basis of the non-superior CRC incidence, we will recruit 1894 patients in each arm. The main endpoint is 10-year CRC incidence and the secondary endpoints are diagnostic yield, participation, adverse effects, mortality and cost-effectiveness. Our results may modify the clinical practice after advanced colonic resection in CRC screening programs.

3.
Gac Sanit ; 22(3): 275-9, 2008.
Article in Spanish | MEDLINE | ID: mdl-18579054

ABSTRACT

To design the processes map of the Galician Department of Public Health, we performed document reviews, held meetings and interviewed persons in charge of programs and departments to identify the processes carried out. The processes were classified into strategic, key and support processes. We defined 4 levels of disaggregation and management and staff were kept informed throughout the process. At level 0, we included 4 key processes that defined the organization's mission. At level 1, 5 strategic, 5 support and 10 key processes were defined. The key processes at level 2 identified the health programs' services. A processes map was obtained by consensus and was then approved by management and staff as a first step in implanting a process management system to improve the organization's performance.


Subject(s)
Organizations/organization & administration , Public Health Administration , Spain
4.
Gac. sanit. (Barc., Ed. impr.) ; 22(3): 275-279, mayo 2008. ilus
Article in Es | IBECS | ID: ibc-66337

ABSTRACT

Con el objetivo de elaborar el mapa de procesos de la Dirección General de Salud Pública gallega, se realizaron revisiones documentales, reuniones y entrevistas a responsables de programas y jefes de servicio para identificar los procesos realizados, que se clasificaron en estratégicos, clave y de apoyo. Se definieron hasta 4 niveles de desagregación, y seinformó a la dirección y a los trabajadores de todo el proceso. En el nivel 0 se incluyeron los 4 procesos clave que definían la misión de la organización y, en el 1, 5 estratégicos, 5 de apoyo y los 10 clave. Los procesos clave de nivel 2 identifican servicios de los programas de salud. Se obtuvo un mapa de procesos consensuado que contaba con la aprobación de la dirección y de los trabajadores como paso previo para laimplantación de un sistema de gestión de procesos como mejora de la gestión en la organización


To design the processes map of the Galician Department ofPublic Health, we performed document reviews, held meetings and interviewed persons in charge of programs and departments to identify the processes carried out. The processes were classified into strategic, key and support processes. We defined 4 levels of disaggregation and management and staff were kept informed throughout the process. At level 0, we included 4 key processes that defined the organization’s mission. At level 1, 5 strategic, 5 support and 10 key processes were defined. The key processes at level 2 identified the healthprograms’ services. A processes map was obtained byconsensus and was then approved by management and staffas a first step in implanting a process management systemto improve the organization’s performance (AU)


Subject(s)
Humans , Health Services Administration/trends , Outcome and Process Assessment, Health Care , Health Services Research , Needs Assessment
SELECTION OF CITATIONS
SEARCH DETAIL
...